Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

R Cervera, R Serrano, G J Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, E de Ramón, V Buonaiuto, Søren Jacobsen, M M Zeher, T Tarr, A Tincani, M Taglietti, G Theodossiades, E Nomikou, M Galeazzi, F Bellisai, P L Meroni, R H W M Derksen, P G D de Groot, M BalevaM Mosca, S Bombardieri, F Houssiau, J-C Gris, I Quéré, E Hachulla, C Vasconcelos, A Fernández-Nebro, M Haro, Z Amoura, M Miyara, M Tektonidou, G Espinosa, M L Bertolaccini, M A Khamashta, on behalf of the Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies)

534 Citations (Scopus)

Abstract

To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the frequency of early manifestations with those that appeared later.
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume74
Issue number6
Pages (from-to)1011-8
ISSN0003-4967
DOIs
Publication statusPublished - 2015

Fingerprint

Dive into the research topics of 'Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients'. Together they form a unique fingerprint.

Cite this